These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 15877651
1. International collaborative study to evaluate a candidate reference preparation to define an appropriate specified limit of anti-D in intravenous immunoglobulin products. Thorpe SJ, Fox B, Heath A, Dolman C, Virata ML, Yu MW, Thorpe R. Vox Sang; 2005 May; 88(4):278-87. PubMed ID: 15877651 [Abstract] [Full Text] [Related]
2. International collaborative study to evaluate candidate reference reagents to standardize haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulin products. Thorpe SJ, Fox B, Sharp G, Heath AB, Behr-Gross ME, Terao E, Virata-Theimer ML, Yu MW. Vox Sang; 2009 Aug; 97(2):160-8. PubMed ID: 19402856 [Abstract] [Full Text] [Related]
3. International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method. Thorpe SJ, Fox B, Sharp G, Heath AB, Behr-Gross ME, Terao E, Virata-Theimer ML, Yu MW. Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):39-50. PubMed ID: 20223189 [Abstract] [Full Text] [Related]
4. International collaborative study to assess candidate reference preparations to control the level of anti-D in IVIG for use in Europe and the United States. Thorpe SJ, Fox B, Heath A, Behr-Gross ME, Virata ML, Yu MY. Biologicals; 2006 Sep; 34(3):209-12. PubMed ID: 16492398 [Abstract] [Full Text] [Related]
6. International standards for minimum potency of anti-A and anti-B blood grouping reagents: evaluation of candidate preparations in an international collaborative study. Thorpe SJ, Fox B, Heath AB, Scott M, de Haas M, Kochman S, Padilla A. Vox Sang; 2006 Nov; 91(4):336-44. PubMed ID: 17105610 [Abstract] [Full Text] [Related]
11. International collaborative study to assess new stocks of candidate reference preparations to control the level of anti-D in IVIG. Thorpe SJ, Virata ML, Fox B, Terao E. Pharmeur Bio Sci Notes; 2024 Nov; 2024():76-89. PubMed ID: 38949845 [Abstract] [Full Text] [Related]
15. Anti-A and anti-B haemagglutinin levels in intravenous immunoglobulins: are they on the rise? A comparison of four different analysis methods and six products. Bellac CL, Polatti D, Hottiger T, Girard P, Sänger M, Gilgen M. Biologicals; 2014 Jan; 42(1):57-64. PubMed ID: 24325871 [Abstract] [Full Text] [Related]
16. International collaborative study to evaluate methods for quantification of anti-D in immunoglobulin preparations. Thorpe SJ, Sands D, Rautmann G, Schäffner G. Vox Sang; 2002 Jul; 83(1):42-50. PubMed ID: 12100388 [Abstract] [Full Text] [Related]
19. Hepatitis A immunoglobulin: an international collaborative study to establish the second international standard. Ferguson M, Sands D, Lelie N. Biologicals; 2000 Dec; 28(4):233-40. PubMed ID: 11237359 [Abstract] [Full Text] [Related]
20. Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulin. Gross S, Janssen SW, de Vries B, Terao E, Daas A, Buchheit KH. Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):11-25. PubMed ID: 20144449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]